Funding Opportunities

• Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01)
  (PA-16-311)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21)
  (PA-16-312)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03)
  (PA-16-313)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
• Characterization of the Adolescent Reproductive Transition (R01)
  (PA-16-314)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Characterization of the Adolescent Reproductive Transition (R21)
  (PA-16-315)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Characterization of the Adolescent Reproductive Transition (R03)
  (PA-16-316)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Administrative Supplements for Research on Dietary Supplements (Admin Supp)
  (PA-16-319)
  Office of Dietary Supplements
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): October 15, 2016; January 15, 2017; or April 15, 2017, by 5:00 PM local time of applicant organization.
• Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)
  (PAR-16-317)
  National Cancer Institute
  Application Receipt Date(s): October 7, 2016; April 11, 2017; October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21)
  (PAR-16-318)
  National Cancer Institute
  Application Receipt Date(s): October 7, 2016; April 11, 2017; October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01)
  (PAR-16-320)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): October 18, 2016; February 17, 2017; June 19, 2017; October 17, 2017; February 15, 2018; June 19, 2018; October 19, 2018; February 15, 2019; and June 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01)
  (PAR-16-321)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03)
  (PAR-16-323)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
• Biophysical and Biomechanical Aspects of Embryonic Development (R21)
  (PAR-16-324)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): September 19, 2016; September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biophysical and Biomechanical Aspects of Embryonic Development (R01)
  (PAR-16-325)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): September 19, 2016; September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Emerging Science and Technology in Transplantation (U01)
  (RFA-AI-16-042)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 20, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Biosensors in the Oral Cavity (R01)
  (RFA-DE-17-004)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): October 19, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Biosensors in the Oral Cavity (R21)
  (RFA-DE-17-005)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): October 19, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Evaluating predictive methods and product performance in Healthy Adults for Pediatric Patients, Case Study: Furosemide (U01)
  (RFA-FD-16-048)
  Food and Drug Administration
  Application Receipt Date(s): August 12, 2016 by 11:59 PM Eastern Time.
• Understanding STI Co-Infection In At Risk and HIV Infected Adolescents and Young Adults (R01)
  (RFA-HD-17-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 17, 2016, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Understanding STI Co-Infection In At Risk and HIV Infected Adolescents and Young Adults (R21)
  (RFA-HD-17-012)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 17, 2016, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.